Results 131 to 140 of about 14,207 (206)

Validation of an AI-Powered Smart Dry Powder Inhaler (RS01X) for Asthma and COPD in a Clinical Setting. [PDF]

Int J Chron Obstruct Pulmon Dis
Chamaon D, Sportel E, Elferink ECM, van der Palen J.   +3 more
europepmc   +1 more source

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study. [PDF]

BMC Pulm Med, 2023
Kocks J, Bosnic-Anticevich S, van Cooten J, Correia de Sousa J, Cvetkovski B, Dekhuijzen R, Dijk L, Garcia Pardo M, Gardev A, Gawlik R, van der Ham I, Janse Y, Lavorini F, Maricoto T, Meijer J, Metz B, Price D, Roman Rodriguez M, Schuttel K, Stoker N, Tsiligianni I, Usmani O, Voorham J, Leving MT.   +23 more
europepmc   +1 more source

An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study). [PDF]

Cureus
Karmakar S, Bhate SG, Barge VB, Kumar VK, Nath AR, Sinha E, Bhagat S, Patil S, Bhushan S, Gadkari R, Barkate H.   +10 more
europepmc   +1 more source

Quantitative Determination of Related Substances in Formoterol Fumarate and Tiotropium in Tiomate Transcaps^® Dry Powder Inhaler [PDF]

Turk J Pharm Sci, 2022
Gondhale PS, Varghese Cheriyan B.
europepmc   +1 more source

Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters. [PDF]

J Aerosol Med Pulm Drug Deliv, 2022
Chrystyn H, Saralaya D, Shenoy A, Toor S, Kastango K, Calderon E, Li T, Safioti G.   +7 more
europepmc   +1 more source

Development and Characterization of Spray-Dried Combined Levofloxacin-Ambroxol Dry Powder Inhaler Formulation. [PDF]

Pharmaceutics
Suraweera RK, Spann KM, Izake EL, Wells TJ, Wang X, Islam N.   +5 more
europepmc   +1 more source

Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate. [PDF]

Clin Pharmacokinet
Hassan MI, Laz NI, Madney YM, Abdelrahim MEA, Harb HS.   +4 more
europepmc   +1 more source

Dry-powder inhaler use in primary school-aged children with asthma: a systematic review. [PDF]

ERJ Open Res
Kuek SL, Wong NX, Dalziel S, Hatter L, Fleming L, Bush A, Beasley R, Shanthikumar S.   +7 more
europepmc   +1 more source

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

JAMA Intern Med
Rabin AS, Seelye SM, Weinstein JB, Hogan CK, Whittington TN, Cano J, Miller SA, Kelley C, Prescott HC.   +8 more
europepmc   +1 more source

Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques. [PDF]

Pharm Res
Farias G, Ganley WJ, Price R, Conti DS, Mangal S, Bielski E, Newman B, Shur J.   +7 more
europepmc   +1 more source